I've been trying to locate a public database that lists the number of shareholders of a particular stock. For example how many persons/institutions are registered as owning NNVC stock?

I'm not interested in names or number of shares registered to a name.

I've owned the same stock at two different brokerages and yet I receive only one annual report. This leads me to believe there is a centralized repository.

Hopefully my question makes sense.

"I think Feelgood has you here. I don't like him but it's true."

What is it you don't "like" about Feelgood? His use of factual information? His in depth knowledge of the science and NNVC's history. His ability to present logical arguments?

I suspect it's the facts you don't like. Not the person.

GaryR,

Your post made me wish IHUB had a "Like" button.

Thanks for the grins.

NNVClover,

The reason H1N1 was a threat was because it emerged after the annual flu vaccine had been produced. You may remember that by the time they came up with a vaccine for H1N1 the strain had pretty much run its course.

The concern is that this scenario my repeat itself with a more deadly strain of flu viruses.

So, in addition to your comment being callous it was ill informed.

Drano,

Apologies. I didn't realize you had posted MN flue stats when I posted.

Golden Valley

Flu deaths rise dramatically in Minnesota
by Lorna Benson, Minnesota Public Radio
March 24, 2011

St. Paul, Minn. — The Minnesota Department of Health has confirmed 12 additional deaths, bringing the total this season to 25.

The deaths were confirmed last week, but they could have occurred earlier in the season. An agency spokesperson wasn't immediately available to explain when all of the deaths occurred.

In a statement on its website, the Health Department said flu activity remained elevated in Minnesota last week. Thirteen schools reported outbreaks, as did 7 long-term care facilities. Last week, 101 people were hospitalized with laboratory-confirmed influenza.

I didn't say heading home. I said starting weekend early. Balmy weather and all.

I'm not trying to be negative. The more people attending Dr. Diwan's presentation the better. Just saying.

Not sure if it is good or bad that Diwan speaking on Friday afternoon. Attendance may be thin due to people starting weekend early.

Then again, a good sized crowd on Friday afternoon would signal a high level of interest.

At most events like this the "real" meetings take place in the hallways, restaurants, and lounges.

A bit disconcerting. I'm hoping it's the lull before the storm.

There isn't any negative news floating around that I'm aware of.

I come to this board to read others' opinions and the discussion of what they feel supports their opinion.

Since I own shares of NNVC I'm drawn more to the positive but I am diligent in giving my attention to well thought out and fact based opposing opinions.

If I were paying someone and they projected a price point that was missed I would question the value of their service.

Anyone on this or any other board saying "In my opinion", "I think", "I'm guessing", or even "I'm hoping" should not be taken to task.

The luxury of holding someone accountable to their opinion can be purchased in the form of advisory fees. Your disagreement can be expressed by ending the financial relationship.

I appreciate this group and enjoy the sense of comradary among the majority of participants. Even when they disagree.

Thank you Dr. Feelgood.

Happy holidays to all from Minneapolis, Minne-snow-da.

Disregard my earlier message. I found PZG on Yahoo discussion.

Greetings. This is my first post on this board. I am strongly considering buying some PZG based on their reserves, financial health, Michael Murphy, and the recommendation of a friend.

Does anyone have opinions or comments they would like to share?

nanopatent,

Your article was an interesting read. Thank you.

This week's Newsweek had an article about the potential relationships of chronic fatigue syndrome to a virus. Naturally the first thing that came to my mind was yet another opportunity for NNVC.

http://www.newsweek.com/2010/11/28/could-a-virus-cause-chronic-fatigue-syndrome.html

DrFeelgood,

Thanks for normalizing the day with your tongue-in-cheek bashing. :)

Someone asked you earlier about the picture on your posts. If you replied I may have missed it. I'm curious about the identity of the two different particles. Which is which?

It's a great picture.

I did not see the "House" episode but I liked the quote because it caused me to think of something I previously had not thought of.

It seems to me that the public would readily accept a nanoviricide. I mention this from the perspective that there are many people who remain suspicious of vaccinations. Even the time tested early ones.

While FDA approval is paramount public acceptance is no small matter and I believe public resistance to 'cide' technology will be minimal.

Thank you for yet another dose of optimism around Nanoviricides.

nanometer,

I am sympathetic to your loss. $15k is not "chump change" to the vast majority of the world's population.

I'm curious whether St. George has additional questionable things going that caused his employer to want to distance themselves from him.

I have not been able to verify this but it may be of some help should you get involved in legal proceedings. I've read reference to St George being an immigrant who changed his name from Rick S Puszakowski to Rick St. George. I do not know if the Puszakowski involved in Eldercare Financial Services is Rick St George.

It has possibilities. Nestle sold the balance of Alcon to Novartis this Fall.

Much like their stake in L'Oreal cosmetics Nestle owned Alcon as a investment holding as a means of diversification from their core food/beverage interests.

I think Novartis will treat Alcon as an opportunity to penetrate the market and grow the business more so than Nestle did.

The potential of NNVC can boggle the mind when trying to comprehend it.

noretreat,

Thank you. True about some posters.

My response was intended for the benefit of what appears to be a great group of regulars.

Yes, good day to buy. Tomorrow may be better? Friday could also be good (short trading day).

IMO NNVC is going to rock in Spring 2011. After that it will get increasingly expensive to accumulate.

I'm the former Novartis employee you are referring to.

The point, and only point, of my post was to address a few comments I saw that seemed to regard Novartis as a potential threat to NNVC. My intent was to allay these concerns. It is my belief that the only threat Novartis may be to NNVC are within the realm of free market enterprise.

Novartis has approximately 180,000 employees. I never presented myself as a Novartis/NNVC contact person. My message was that of respecting a company in which I had over a decade of experience.

If any pharma company expresses interest in working with NNVC I would regard that as strong message of reinforcing the legitimacy of NNVC to the investment community.

An obvious benefit to those of us long on NNVC.

I was in IT when I was with Novartis and it's been a few years. I had very little interaction with the R&D folk in Cambridge or Florham Park so I have no relevant contacts.

As a former Novartis employee I question the suspicions that Novartis would do something nefarious to NNVC.

I firmly believe that of all the large pharma companies Novartis is the more ethical of the bunch.

Novartis is constantly on the look out for start up companies with high potential and if things line up they will offer to partner with the company. This usually involves a cash infusion (if needed), partnering in research, assisting with and expediting the FDA process, and providing a distribution channel to get the product out.

Novartis prefers mutually beneficial relationships.

Novartis has worked closely with WHO (World Health Organization)to develop a phenomenal global distribution organization for the treatment and prevention of malaria. A treatment for Dengue ties in nicely.

In my opinion Novartis proved their ethical commitment when they were interested in Aventis in 2004. Aventis didn't want to be bought and Novartis backed off as they would not be party to a hostile take over. Sanofi acquired Aventis in a hostile buy out.

If NNVC ties in with a larger pharma company I don't think they could do much better than Novartis.

I'm out of SUNVE. Lost over 50% but investment was small.

If Rick St George, and Carl what's-his-name did a verified PR about having genetically modified a goose to lay golden eggs I still wouldn't buy into it. They would mess it up one way or another.

I wonder if local investors are circling Rick, Carl, & partners' houses while carrying pitchforks and torches.

Things are pretty bad when even though taking a hit as I did I still felt a sense of relief to be shed of those pricks.

Was anything said about an agreement between SUNV & Sylvania?

A friend of mine in the medical research field jokingly says the acronym FDA stands for "Further Delays Ahead".

However, like most government agencies, the FDA is subject to political and public pressure. It can be as simple as moved to the front of the FDA queue. An accelerated approval does not necessarily equate increased risk.

I'm of the belief that once the foundation components of the viricide gain approval the variations will ride on the established credibility of the foundation.

The Dengue fever issue could serve to accelerate FDA approval.

In 2001 Novartis was working with a drug called Gleevec that was found to help with chronic myeloid leukemia a typically fatal disease.

The FDA gave Gleevec an unprecedented rapid approval (2 1/2 months) due to the serious nature of the disease and the hope it could help.

My point is that if Dengue becomes increasingly problematic it is possible that FDA approval could be expedited.

A rapid approval would serve humanity, NNVC, and investors well.

ErnieBilco,

I'm eager to hear your opinion of how the Nov 17 shareholder meeting went. I suspect there will be some seriously upset people there. People who have put up a lot of money only to see it dwindle to .04 a share.

Will management be able to look people in the eye and give straight answers? Or attempt to spin?

One thing I hope gets mentioned is that it seems they issue a PR announcing having hired a new 'wunderkind'. So we eagerly wait for the next PR that will announce results. Instead we hear of yet a another new exciting well pedigreed hire.

Did you notice in the annual report that part of their relocation deal with the County involved creating 25(?)new jobs? I don't think the County meant importing 25 senior managers.

P.S. I voted 'No' on the proposed stock incentive plan.

I got my proxy statement today.

I live in MN so won't be at shareholder meeting.

Would much appreciate your opinion after the meeting.

This has nothing to do with DNAPrint Genomics. There is a DNAG stock symbol (formerly DNAP)affiliated with DNAPrint Genomics and apparently a different company named DNAG that is mentioned in this article.

The DNAPrint (current symbol DNAG)and DNAG company aren't one and the same.

You can form a company named KO but that doesn't make it Coca Cola.

Buckster,

Hey, no problem.

I like this board. The people that frequent this site seem intelligent, knowledgeable, and open minded.

I am not 100% certain these aren't Sunovia products. Prior to Sunovia I had never heard of "cobra head" light fixtures so I'm no expert. My only thought was that they didn't mention the aiming feature in the ad. Perhaps by now this feature has attained the status of given knowledge.

I'm under the impression that Sunovia has a rather large base of distributors. I remember being concerned about there being enough margin to support going through distributors.

I was under the impression that cobra head was a generic description of a type of light and what made Sunovia unique was the ability to aim the individual bulbs to maximize efficiency. Another selling feature was the ability to use existing cobra head poles and extension arms to install the Sunovia cobra head fixture.

Based on this I'm not convinced these are Sunovia products. Please correct me if I am wrong. After viewing the website I would prefer to be proven wrong. :)

Positive news. Sunovia lamps installed at De Paul U parking facility(s).

http://finance.yahoo.com/news/DePaul-University-Goes-Green-prnews-2166014121.html?x=0&.v=1

'nanometer' - As a moderator on this board I struggled with whether your post should stay or go. I felt that, in a sense, you were voicing your frustration. Many of us have. My decision was to let your post stand.

Disclosure. I own apx 26k shares of SUNV and while I would like nothing more than to see them succeed I do have concerns.

Here is my hope. Legacy senior management realized they were in trouble and lacked the experience/expertise to correct it(I like to think they were reading our posts). After reading the court documents the new CEO, who has a proven track record, saw potential where the existing management didn't and was confident enough that he could turn SUNV around that he is staking his reputation on it.

Here is my fear. The new CEO saw a pile of easy cash in the form of shares and stopped by long enough to pick it up.

Currently I am hanging onto my hope.

I also saw it as a way of bringing in new dollars. SUNV seems to be more about image than substance.

The net result is an increase by one expensive head count.

I'm curious about what all these managers are managing.

New CEO at Sunovia

http://finance.yahoo.com/news/Art-Buckland-Hired-as-New-prnews-3393440295.html?x=0&.v=1

Ernie - I think your comment nails it, "I would think that if SUNV had any valid claim they would have filed suit BEFORE putting out their PR."

The basis for my comment around this was an earlier post on this site where it was reported that SUNV did the PR to nudge EIPR into action.

SUNV publicly announced (blustered)they had a viable issue and then didn't follow through. Based on SUNV's PR they now have a serious and documented credibility issue.

EIPR files against SUNV in criminal court.

IMO, someone lied big time and can't deliver. And I think it's SUNV.

What I am not understanding is why EIPR is suing SUNV. According to SUNV, EIPR was in breach of a contracted deliverable and this is how the whole brouhaha got started,

SUNV issued a PR stating that they're suing EIPR and then doesn't appear to act on the threat. Later SUNV gets taken to criminal court by EIPR.

Did SUNV not take action because they were unable to find an attorney who thought they had a merit-able case?

What does SUNV have the EIPR wants? I doubt that it's their lamp aiming ability. It certainly can't be SUNV's customer base as they don't appear to have one.

I'm not understanding this at all but I would like to think there's a large enough amount of money involved to interest regulatory agencies.

This play has certainly been disappointing. I am also unable to justify trying to average down.

My concern is that they're no longer bothering with puff releases to keep the share price pumped up. They're now sitting in a publicly subsidized building for which I doubt there is any kind of lease buy out should they fold their tents.

I wonder if this wasn't a well played sting with stimulus funding, green energy, and emerging technologies serving as props.

TBF was started by the founder of DNAP (DNAPrint Genomics - Sarasota,FL) as an effort to raise funding. The partners of TBF partners struck a deal with Dutchess hedge fund as a $35mm investor in DNAP. When hedge funding dried up at mid-point the founder of DNAPrint/TBF was forced out and his company run into the ground. Dutchess foreclosed on DNAP.

Tony Frudakis, founder of DNAP & originator of TBF, is a brilliant scientist but was not business savvy. Tony has signed a deal to do research with SUNV for cash and 23mio shares.

This interested me in SUNV as I saw Tony as being a strong asset and, after DNAP, a lot more business savvy. An acquaintance of mine with deeper knowledge of TBF than me said there were some familiar names from the earlier TBF now tied into SUNV.

I still feel if SUNV sticks to their core competencies of lighting and solar they may do okay. If SUNV starts chasing rabbits and churning out press releases in the interest of generating excitement without producing results I will then become concerned about a repeat of events.

I think most will agree that we'd prefer SUNV provide us with concrete facts instead of press puff.

Back to my original question. How does "Chicago" tie into SUNV? My question is sincere.

Buckster71,

I'm missing the "Chicago" connection. What is that about? I'm not disagreeing just asking for enlightenment.

I had some trepidation about getting involved in SUNV as some of the players are associated with Tampa Bay Financial. It seems that everything they touch turns to crap. Except for them of course.

I wish I had listened to my gut feeling. Oh well, at least I didn't bet more than I could afford to lose.